Back to top
more

Fulgent Genetics (FLGT)

(Delayed Data from NSDQ)

$20.01 USD

20.01
136,343

-0.17 (-0.84%)

Updated Jul 9, 2024 04:00 PM ET

After-Market: $20.03 +0.02 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (147 out of 250)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Fulgent Genetics' (FLGT) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Fulgent Genetics (FLGT).

Urmimala Biswas headshot

4 MedTech Stocks Up More Than 100% in 2020 With Room to Run

We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.

Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial

Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial

Rimmi Singhi headshot

5 High Earnings Yield Bets Amid an Uncertain Santa Rally

Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback.

Health Catalyst (HCAT) Catches Eye: Stock Jumps 5.1%

Health Catalyst (HCAT) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

The Zacks Analyst Blog Highlights: Addus HomeCare, Fulgent Genetics and Hologic

The Zacks Analyst Blog Highlights: Addus HomeCare, Fulgent Genetics and Hologic

3 MedTech Growth Stocks With Solid Prospects for 2021

Here are a few MedTech growth stocks poised for a rebound that investors can scoop up to reap profits going into 2021.

Top Ranked Momentum Stocks to Buy for December 10th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 10th

Omnicell (OMCL) Looks Good: Stock Adds 5% in Session

Omnicell (OMCL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Senseonics Holdings (SENS) Surges: Stock Moves 5.2% Higher

Senseonics Holdings (SENS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Nalak Das headshot

Wall Street Regains Momentum on Vaccine Hopes: 5 Top Picks

Investment in momentum stocks with a favorable Zacks Rank may be fruitful in the near term. These include Fulgent Genetics (FLGT), II-VI (IIVI), General Motors (GM), Flagstar Bancorp (FBC) and Lear (LEA).

Top Ranked Momentum Stocks to Buy for November 17th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 17th

Illumina-CDGN Partner to Create Coronavirus Tracking System

Illumina (ILMN) partners with Australia's CDGN to track the national transmission of the virus causing COVID-19.

Strength Seen in Fulgent Genetics (FLGT): Stock Soars 11.6%

Fulgent Genetics (FLGT) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.

Zacks.com featured highlights include: Fulgent Genetics, Primoris Services, Niu Technologies, Surface Oncology and Aldeyra Therapeutics

Zacks.com featured highlights include: Fulgent Genetics, Primoris Services, Niu Technologies, Surface Oncology and Aldeyra Therapeutics

Shrabana Mukherjee headshot

5 Stocks to Buy as Analysts Initiate Coverage

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Earnings Estimates Moving Higher for FULGENT GENETIC (FLGT): Time to Buy?

FULGENT GENETIC (FLGT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

FULGENT GENETIC (FLGT) Q2 Earnings and Revenues Beat Estimates

FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 1600.00% and 18.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

FULGENT GENETIC (FLGT) Reports Q1 Loss, Tops Revenue Estimates

FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 0.00% and 0.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Will FULGENT GENETIC (FLGT) Report Negative Earnings Next Week? What You Should Know

FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FULGENT GENETIC (FLGT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Fulgent Genetics (FLGT) Q4 Earnings?

Fulgent Genetics' (FLGT) fourth-quarter 2019 earnings are likely to reflect top-line growth and elevated test volumes.

Sweta Killa headshot

5 Top-Ranked Stocks Beating the Market at Midway Q1

Better-than-expected earnings, positive development in the U.S.-China trade relationship, China stimulus measures, easing policies and slew of upbeat economic data buoyed the stocks.

Zacks.com featured highlights include: AQN, IDN, FLGT and SMED

Zacks.com featured highlights include: AQN, IDN, FLGT and SMED

Nitish Marwah headshot

4 Breakout Stocks for Explosive Returns

Picking breakout stocks is one of the most favored methods for those utilizing an active investing approach since this strategy offers the scope of superlative returns.